SMIM
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.10.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 17.10.12 | Roche outperform | Exane-BNP Paribas SA | |
| 16.10.12 | Roche outperform | Cheuvreux SA | |
| 16.10.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 16.10.12 | Kühne + Nagel International equal-weight | Morgan Stanley | |
| 16.10.12 | Kühne + Nagel International hold | Deutsche Bank AG | |
| 16.10.12 | Kühne + Nagel International buy | Nomura | |
| 15.10.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 15.10.12 | Roche buy | Sarasin Research | |
| 15.10.12 | Kühne + Nagel International hold | Vontobel Research | |
| 12.10.12 | SGS SA buy | Vontobel Research | |
| 12.10.12 | Roche outperform | Exane-BNP Paribas SA | |
| 12.10.12 | Roche neutral | Nomura | |
| 12.10.12 | Roche outperform | Credit Suisse Group | |
| 11.10.12 | Roche buy | Deutsche Bank AG | |
| 11.10.12 | Swisscom neutral | Nomura | |
| 11.10.12 | Temenos outperform | Exane-BNP Paribas SA | |
| 11.10.12 | Kühne + Nagel International hold | Vontobel Research | |
| 11.10.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 11.10.12 | EMS-CHEMIE hold | Vontobel Research | |
| 10.10.12 | Swatch (I) outperform | Credit Suisse Group | |
| 10.10.12 | Kühne + Nagel International underperform | Cheuvreux SA | |
| 10.10.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 10.10.12 | Julius Bär buy | Nomura | |
| 10.10.12 | EMS-CHEMIE hold | Vontobel Research | |
| 10.10.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 10.10.12 | EMS-CHEMIE buy | Sarasin Research | |
| 10.10.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 09.10.12 | Kühne + Nagel International buy | Nomura | |
| 09.10.12 | Julius Bär buy | Sarasin Research | |
| 08.10.12 | Swatch (I) neutral | J.P. Morgan Cazenove | |
| 05.10.12 | Sonova neutral | Sarasin Research | |
| 05.10.12 | Roche kaufen | Fuchsbriefe | |
| 05.10.12 | Straumann hold | Vontobel Research | |
| 05.10.12 | Sonova buy | Vontobel Research | |
| 04.10.12 | Roche outperform | Cheuvreux SA | |
| 04.10.12 | Swatch (I) buy | Sarasin Research | |
| 04.10.12 | Swatch (I) buy | Vontobel Research | |
| 02.10.12 | Roche neutral | Nomura | |
| 02.10.12 | Roche overweight | J.P. Morgan Cazenove |